75 related articles for article (PubMed ID: 22027337)
1. Rapid identification of CYP2C8 polymorphisms by high resolution melting analysis.
Chang CC; Lin PC; Lin CH; Yeh KT; Hung HY; Chang JG
Clin Chim Acta; 2012 Jan; 413(1-2):298-302. PubMed ID: 22027337
[TBL] [Abstract][Full Text] [Related]
2. A simple multiplex PCR method for the concurrent detection of three CYP2C8 variants.
Muthiah YD; Lee WL; Teh LK; Ong CE; Salleh MZ; Ismail R
Clin Chim Acta; 2004 Nov; 349(1-2):191-8. PubMed ID: 15469873
[TBL] [Abstract][Full Text] [Related]
3. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a rapid and reliable method for cytochrome P450 2C8 genotyping.
Weise A; Grundler S; Zaumsegel D; Klotzek M; Gröndahl B; Forst T; Pfützner A
Clin Lab; 2004; 50(3-4):141-8. PubMed ID: 15074466
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of CYP2C8 in hypertensive patients using denaturing high performance liquid chromatography.
Teh LK; Zahri MK; Zakaria ZA; Ismail R; Salleh MZ
J Clin Pharm Ther; 2010 Dec; 35(6):723-8. PubMed ID: 21054465
[TBL] [Abstract][Full Text] [Related]
6. Relevance of nonsynonymous CYP2C8 polymorphisms to 13-cis retinoic acid and paclitaxel hydroxylation.
Rowbotham SE; Boddy AV; Redfern CP; Veal GJ; Daly AK
Drug Metab Dispos; 2010 Aug; 38(8):1261-6. PubMed ID: 20421446
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of five novel CYP2C8 variants, G171S, R186X, R186G, K247R, and K383N, found in a Japanese population.
Hichiya H; Tanaka-Kagawa T; Soyama A; Jinno H; Koyano S; Katori N; Matsushima E; Uchiyama S; Tokunaga H; Kimura H; Minami N; Katoh M; Sugai K; Goto Y; Tamura T; Yamamoto N; Ohe Y; Kunitoh H; Nokihara H; Yoshida T; Minami H; Saijo N; Ando M; Ozawa S; Saito Y; Sawada J
Drug Metab Dispos; 2005 May; 33(5):630-6. PubMed ID: 15716363
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of CYP2C8 in three Malaysian ethnics: CYP2C8*2 and CYP2C8*3 are found in Malaysian Indians.
Muthiah YD; Lee WL; Teh LK; Ong CE; Ismail R
J Clin Pharm Ther; 2005 Oct; 30(5):487-90. PubMed ID: 16164496
[TBL] [Abstract][Full Text] [Related]
9. Identification of a synonymous polymorphism within the cytochrome P4502C9 gene that interferes with identification of the CYP2C9*2 allele.
Womack EP; Reynolds KK; Valdes R; Linder MW
Ther Drug Monit; 2007 Oct; 29(5):607-11. PubMed ID: 17898651
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of CYP2C8 polymorphisms in a North Indian population.
Minhas S; Setia N; Pandita S; Saxena R; Verma IC; Aggarwal S
Genet Mol Res; 2013 Jul; 12(3):2260-6. PubMed ID: 23884769
[TBL] [Abstract][Full Text] [Related]
11. High resolution melting analysis facilitates mutation screening of ETFDH gene: applications in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
Er TK; Liang WC; Chang JG; Jong YJ
Clin Chim Acta; 2010 May; 411(9-10):690-9. PubMed ID: 20138856
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of CYP2C8.13 and CYP2C8.14: catalytic activities toward paclitaxel.
Hanioka N; Matsumoto K; Saito Y; Narimatsu S
Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):565-9. PubMed ID: 20148860
[TBL] [Abstract][Full Text] [Related]
13. Genetic variance in CYP2C8 and increased risk of myocardial infarction.
Rodenburg EM; Visser LE; Danser AH; Hofman A; van Noord C; Witteman JC; Uitterlinden AG; Stricker BH
Pharmacogenet Genomics; 2010 Jul; 20(7):426-34. PubMed ID: 20436375
[TBL] [Abstract][Full Text] [Related]
14. Rapid identification of HBB gene mutations by high-resolution melting analysis.
Shih HC; Er TK; Chang TJ; Chang YS; Liu TC; Chang JG
Clin Biochem; 2009 Nov; 42(16-17):1667-76. PubMed ID: 19631632
[TBL] [Abstract][Full Text] [Related]
15. High resolution melting for mutation scanning of TP53 exons 5-8.
Krypuy M; Ahmed AA; Etemadmoghadam D; Hyland SJ; ; DeFazio A; Fox SB; Brenton JD; Bowtell DD; Dobrovic A
BMC Cancer; 2007 Aug; 7():168. PubMed ID: 17764544
[TBL] [Abstract][Full Text] [Related]
16. Detection and identification of cytochrome P-450 2C9 alleles *1, *2, and *3 by high-resolution melting curve analysis of PCR amplicons.
Hill CE; Duncan A; Wirth D; Nolte FS
Am J Clin Pathol; 2006 Apr; 125(4):584-91. PubMed ID: 16627267
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms and functional characterization of the 5'-flanking region of the human CYP2C9 gene: in vitro and in vivo studies.
Shintani M; Ieiri I; Inoue K; Mamiya K; Ninomiya H; Tashiro N; Higuchi S; Otsubo K
Clin Pharmacol Ther; 2001 Aug; 70(2):175-82. PubMed ID: 11503012
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of five CYP2C8 variants and prediction of CYP2C8 genotype-dependent effects on in vitro and in vivo drug-drug interactions.
Gao Y; Liu D; Wang H; Zhu J; Chen C
Xenobiotica; 2010 Jul; 40(7):467-75. PubMed ID: 20459297
[TBL] [Abstract][Full Text] [Related]
19. First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant.
Cauffiez C; Lo-Guidice JM; Chevalier D; Allorge D; Hamdan R; Lhermitte M; Lafitte JJ; Colombel JF; Libersa C; Broly F
Hum Mutat; 2004 Jan; 23(1):101. PubMed ID: 14695544
[TBL] [Abstract][Full Text] [Related]
20. [A new, rapid and robust genotyping method for CYP2C9 and MDR1].
Verstuyft C; Morin S; Yang J; Loriot MA; Barbu V; Kerb R; Brinkmann U; Beaune P; Jaillon P; Becquemont L
Ann Biol Clin (Paris); 2003; 61(3):305-9. PubMed ID: 12805007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
